{
  "docId": "019de070-9f9d-7718-acb6-17a3db6270ac",
  "docSlug": "7a58434f86a94bb0eba92fad9f688c31",
  "documentTitle": "23andMe | SPAC Presentation Deck | 47 slides",
  "authorId": "23andme",
  "authorName": "23andMe",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 26,
  "pageCount": 47,
  "prevPage": 25,
  "nextPage": 27,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "The slide uses a split-screen layout with a blue background on the left for the core problem statement and a white background on the right for supporting metrics.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-9f9d-7718-acb6-17a3db6270ac/26",
  "deckHref": "/decks/019de070-9f9d-7718-acb6-17a3db6270ac",
  "deckJsonHref": "/decks/019de070-9f9d-7718-acb6-17a3db6270ac.json",
  "deckAnchorHref": "/decks/019de070-9f9d-7718-acb6-17a3db6270ac#slide-26",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.12,
        "x": 0.68,
        "y": 0.62
      },
      "kind": "metric",
      "text": "$2.6B average cost of drug development",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "72c53c36-1ee6-4612-be60-f16c6cdcd06f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.12,
        "x": 0.58,
        "y": 0.345
      },
      "kind": "metric",
      "text": "7 years average time-to-IND",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c11b6148-a6f6-4e25-a380-de32ac5f29f6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.12,
        "x": 0.78,
        "y": 0.345
      },
      "kind": "metric",
      "text": "~90% failure rate",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c2ab00db-5492-4d2a-8e1d-58a7cd67dab8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.48,
        "x": 0.01,
        "y": 0.93
      },
      "kind": "source-note",
      "text": "IND = Investigational New Drug Application. fdareview.org, “The Drug Development and Approval Process” (2020). Probability of success for a drug to be approved is estimated to be <12%. PhRMA, “Biopharmaceutical Research & Development: The Process Behind New Medicines” (2015).",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d68f6580-abf8-463c-b6f4-37a8b36f31e8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.4,
        "x": 0.05,
        "y": 0.3
      },
      "kind": "title",
      "text": "Limited Use of Data and Lack of Patient Engagement Constrains Productivity",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d209ab5b-f284-410f-adbb-faab87ed035f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.55,
        "y": 0.12
      },
      "kind": "title",
      "text": "Drug Development is Inefficient",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1b5b4cfb-a26a-4e33-a6ce-93a2083e7dc2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Problem Statement Canvas",
      "slug": "problem-statement-canvas",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "4fcb8077-8b40-4dde-ad2e-1a340b269d68",
      "evidence": "The slide presents a problem statement with key metrics and a clear headline, indicating the use of a problem statement canvas.",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 30,
      "from": 21,
      "beatId": "128379fa-90aa-4c0d-b5c6-fef3f5f859b3",
      "arcName": "Rags to Riches",
      "arcSlug": "rags-to-riches",
      "beatName": "The Breakthrough",
      "beatSlug": "rags-to-riches-the-breakthrough",
      "evidence": "The deck presents 23andMe's breakthroughs in therapeutics discovery and development",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 30,
      "from": 26,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "f21fb50b-1139-4a89-a2de-f93a9b6f603d",
      "evidence": "The deck highlights the limitations of current therapeutics development approaches",
      "position": 1,
      "objective": "The cost of inaction in therapeutics development",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}